Randomized controlled clinical trial of Dan Zhi Jiang Tang Capsule in treating type 2 diabetes mellitus with Qi Yin deficiency and blood stasis syndrome

the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18 to 75 years (including both ends), gender is not limited;
•2. Patients with type 2 diabetes who meet the diagnostic criteria of Western medicine for diabetes;
•3. Those who conform to the syndrome of qi and yin deficiency in traditional Chinese medicine with blood stasis;
•4. Those who only received metformin hydrochloride tablets, and 0.5g/time, 3 times/day, not less than 2 weeks;
•5. Poor control: blood sugar [6.5mmol/L<=FPG (venous blood)=10.0mmol/L; 7.0%6. Patients were informed and signed the informed consent voluntarily.

•1. Patients with type 2 diabetes who need insulin therapy;
•2. Patients with acute complications of diabetes;
•3. Combined with severe cardiovascular and cerebrovascular diseases and serious primary diseases such as liver, kidney and hematopoietic system;
•4. Those who are allergic to the known ingredients of the research drug and have allergic constitution;
•5. Pregnant, lactating patients and those who have a childbearing plan in the near future;
•6. Long-term alcoholism, drug dependence, mental illness patients;
•7. Patients who have taken oral Chinese medicine or Chinese patent medicine for hypoglycemic purpose within 1 month before screening;
•8. Those who have participated in or are participating in other drug clinical trials within one month before the screening period of this study;
•9. The researcher believes that it is not suitable to participate in this clinical study.

发起方

the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine